Hepatocellular carcinoma (HCC) is one of the most prevalent and lethal causes of cancer-
related death worldwide. The treatment of HCC remains challenging and is largely …

Hepatocellular carcinoma (HCC) is the third leading cause of cancer death worldwide.
Surveillance for HCC is critical for early detection and treatment, but fewer than one-quarter …

Hepatocellular carcinoma (HCC) is one of the main cancer-related causes of death
worldwide. Thus, there is a constant search for improvement in screening, diagnosis, and …

Purpose Most patients with hepatocellular carcinoma (HCC) have associated chronic liver
disease, the severity of which is currently assessed by the Child-Pugh (CP) grade. In this …

Background & Aims GALAD and BALAD-2 are statistical models for estimating the likelihood
of the presence of hepatocellular carcinoma (HCC) in individual patients with chronic liver …

Background: The effectiveness of tumor markers in evaluating outcomes of patients with
hepatocellular carcinoma (HCC) remains to be clarified. Summary: The usefulness of the …

Background: Hepatocellular carcinoma (HCC) is one of the leading causes of death in
cirrhotic patients worldwide. The detection rate for early stage HCC remains low despite …

Hepatocellular carcinoma (HCC) is the fifth most common cancer and the third leading
cause of cancer-related death worldwide. Due to the lack of efficient tools for early detection …

Hepatocellular carcinoma (HCC) is the most common type of primary liver cancer with high
mortality. The realization of precision medicine in HCC relies upon efficient biomarkers …

Biomarkers for surveillance, diagnosis and prediction of prognosis in patients with
hepatocellular carcinoma (HCC) are currently not ready for introduction into clinical practice …